Bacterial Conjunctivitis Drugs Market Demand and Opportunity in 2013 to 2024
As the U.S. market for bacterial conjunctivitis drugs becomes increasingly crowded, companies' profitability faces a major setback, finds a new study by Transparency Market Research (TMR). The growing fragmentation in this market is leading to intense competition among players, leaving them with meager individual shares. New entrants, in spite of having strong research and development capabilities, lack proper financing and capital help, whereas the huge cost burden involved in research and development limits production activities of established participants. In 2013,...
View full press release